Ascendia
Zhifeng Zhao is an accomplished Formulation Scientist at Ascendia, leading drug product development activities since January 2022. With a doctoral degree in Pharmaceutical Sciences from the University of Nebraska Medical Center, obtained in May 2022, Zhifeng contributed to research as a Graduate Research Assistant from August 2017 to January 2022, focusing on glucocorticoid-based nanomedicine formulations under the supervision of Dr. Dong Wang. Prior experience includes a role as an Undergraduate Research Assistant at Fudan University, where guested prodrugs were synthesized, and a summer internship at Boehringer Ingelheim, involving impurity analysis via HPLC. Additional experience includes providing peer support to international students and serving as a Teaching Assistant for pharmaceutical courses. Academic credentials include a Bachelor's degree in Pharmaceutical Sciences from Fudan University, completed in 2017.
Ascendia
1 followers
Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates. It specializes in improving the solubility and bioavailability of poorly water-soluble drugs using its suite of nanotechnology platforms. Ascendia formulates products for injectable, oral, and topical routes ofadministration. The company has three technology platforms - EmulSol for producing nano-emulsions, AmorSol for creating amorphous solid dispersions, and NanoSol for formulating nano-particles.